Re: coldn brought this up on the rvx board...

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Albertaclipper

Rank: Treasurer [?]

Points: 303 [?]

Votes: 7 Score: 2.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: coldn brought this up on the rvx board...

in response to

coldn brought this up on the rvx board...

fuzzyjr

posted on May 13, 2019 01:41PM

I have heard it often mentioned if Zenith sells zen3694 that all zenith shareholders would receive a sizable dividend shortly after. As Tada suggested recently, the next 1-7 months should be interesting!